AGP Executive Report
Last update: 6 hours agoPBS update: Neffy, the adrenaline nasal spray for anaphylaxis, has been added to Australia’s Pharmaceutical Benefits Scheme, giving about 150,000 people access with a $25 dose price—while advocates warn the wider PBS pipeline is still too slow for some patients. Connected care readiness: A new Black Book Market Research report says 99% of providers support connected-care benefits for 1 July 2026 My Health Record share-by-default, but 92% flag practical gaps in workflow, auditability and vendor accountability. Mental health & psychedelics: Optimi Health says it has completed another commercial export of 5mg psilocybin capsules to Australia for treatment-resistant depression, marking its third shipment since launch. First aid & prevention: Mount Gambier councils are urging residents to report thefts of public AED defibrillators after multiple devices were stolen, threatening emergency response in cardiac arrests. Men’s health support: South Australia’s Skylight and local partners are running “Coffee and Chat” sessions for men to encourage connection and discuss wellbeing issues. Bird flu watch: Authorities confirm additional H5 avian flu cases in Australia, with wildlife monitoring ramped up.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![[Latest] Global Neonatal Infant Care Market Size/Share Worth USD 8.94 Billion by 2035 at a 7.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/26243376-923052708-north-america-neonatal-infant-care-market-size-2025-to-2035-usd-billion--100x46.png)
